Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy.

Mönch D, Bode-Erdmann S, Kalla J, Sträter J, Schwänen C, Falkenstern-Ge R, Klumpp S, Friedel G, Ott G, Kalla C.

Oncotarget. 2018 Apr 17;9(29):20781-20794. doi: 10.18632/oncotarget.25111. eCollection 2018 Apr 17.

2.

Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course.

Heß K, Purrucker J, Hegenbart U, Brokinkel B, Berndt R, Keyvani K, Monoranu CM, Löhr M, Reifenberger G, Munoz-Bendix C, Kalla J, Groß J, Schick U, Kollmer J, Klapper W, Röcken C, Hasselblatt M, Paulus W.

Brain Pathol. 2018 Mar;28(2):234-239. doi: 10.1111/bpa.12493. Epub 2017 Mar 13.

PMID:
28160367
3.

Durably reducing transphobia: A field experiment on door-to-door canvassing.

Broockman D, Kalla J.

Science. 2016 Apr 8;352(6282):220-4. doi: 10.1126/science.aad9713.

4.

Editorial Bias in Crowd-Sourced Political Information.

Kalla JL, Aronow PM.

PLoS One. 2015 Sep 2;10(9):e0136327. doi: 10.1371/journal.pone.0136327. eCollection 2015.

5.

Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.

Gruber K, Horn H, Kalla J, Fritz P, Rosenwald A, Kohlhäufl M, Friedel G, Schwab M, Ott G, Kalla C.

J Thorac Oncol. 2014 Mar;9(3):307-15. doi: 10.1097/JTO.0000000000000068.

6.

Corticomedullary differentiation and maturational arrest in thymomas.

Ströbel P, Hartmann E, Rosenwald A, Kalla J, Ott G, Friedel G, Schalke B, Kasahara M, Tomaru U, Marx A.

Histopathology. 2014 Mar;64(4):557-66. doi: 10.1111/his.12279. Epub 2013 Nov 18.

PMID:
24236644
7.

Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.

Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A, Ott G.

Haematologica. 2011 Sep;96(9):1327-34. doi: 10.3324/haematol.2011.042531. Epub 2011 Jun 9.

8.

Take Heart America: A comprehensive, community-wide, systems-based approach to the treatment of cardiac arrest.

Lick CJ, Aufderheide TP, Niskanen RA, Steinkamp JE, Davis SP, Nygaard SD, Bemenderfer KK, Gonzales L, Kalla JA, Wald SK, Gillquist DL, Sayre MR, Osaki Holm SY, Oakes DA, Provo TA, Racht EM, Olsen JD, Yannopoulos D, Lurie KG.

Crit Care Med. 2011 Jan;39(1):26-33. doi: 10.1097/CCM.0b013e3181fa7ce4. Erratum in: Crit Care Med. 2011 Apr;39(4):930. Oski Holm, Susie Y [corrected to Osaki Holm, Susie Y].

PMID:
20890185
9.

A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens.

Horn H, Pott C, Kalla J, Dreyling M, Rosenwald A, Ott G, Schwab M, Schaeffeler E.

Pharmacogenet Genomics. 2010 Oct;20(10):598-604. doi: 10.1097/FPC.0b013e32833deb16.

PMID:
20802378
10.

Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.

Stöcklein H, Hutter G, Kalla J, Hartmann E, Zimmermann Y, Katzenberger T, Adam P, Leich E, Höller S, Müller-Hermelink HK, Rosenwald A, Ott G, Dreyling M.

J Hematop. 2008 Sep;1(2):85-95. doi: 10.1007/s12308-008-0008-6. Epub 2008 Jul 5.

11.

Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.

Hutter G, Scheubner M, Ott G, Zimmermann Y, Hübler K, Roth S, Stilgenbauer S, Kalla J, Stöcklein H, Hiddemann W, Dreyling M.

Ann Hematol. 2009 Sep;88(9):821-8. doi: 10.1007/s00277-008-0686-2. Epub 2009 Jan 10.

PMID:
19137297
12.

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score.

Höller S, Horn H, Lohr A, Mäder U, Katzenberger T, Kalla J, Bernd HW, Went P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

J Hematop. 2009 Sep 2;2(4):187-94. doi: 10.1007/s12308-009-0044-x.

13.

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.

Katzenberger T, Kalla J, Leich E, Stöcklein H, Hartmann E, Barnickel S, Wessendorf S, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

Blood. 2009 Jan 29;113(5):1053-61. doi: 10.1182/blood-2008-07-168682. Epub 2008 Oct 31.

14.

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.

Katzenberger T, Kienle D, Stilgenbauer S, Höller S, Schilling C, Mäder U, Puppe B, Petzoldt C, Sander S, Bullinger L, Stöcklein H, Kalla J, Hartmann E, Adam P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

Br J Haematol. 2008 Aug;142(4):538-50. doi: 10.1111/j.1365-2141.2008.07199.x. Epub 2008 Jun 28.

PMID:
18564361
15.

Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.

Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T, Kalla J, Ott G, Müller-Hermelink HK, Barth TF, Möller P, Lichter P, Döhner H, Stilgenbauer S.

Haematologica. 2008 May;93(5):680-7. doi: 10.3324/haematol.12330. Epub 2008 Mar 26.

16.

Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.

Stöcklein H, Smardova J, Macak J, Katzenberger T, Höller S, Wessendorf S, Hutter G, Dreyling M, Haralambieva E, Mäder U, Müller-Hermelink HK, Rosenwald A, Ott G, Kalla J.

Oncogene. 2008 Apr 17;27(18):2613-25. Epub 2007 Nov 5.

PMID:
17982487
17.

[Severe foetal growth retardation in a patient with uterus bicornis, velamentous insertion and partial placental abruption in the 26th week of gestation--a case report].

Djakovic A, Rieger L, Wirbelauer J, Kalla J, Dietl J.

Z Geburtshilfe Neonatol. 2007 Aug;211(4):169-73. German.

PMID:
17729205
18.

Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.

Kienle D, Katzenberger T, Ott G, Saupe D, Benner A, Kohlhammer H, Barth TF, Höller S, Kalla J, Rosenwald A, Müller-Hermelink HK, Möller P, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2007 Jul 1;25(19):2770-7. Epub 2007 Jun 11.

PMID:
17563396
19.

Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.

Neben K, Ott G, Schweizer S, Kalla J, Tews B, Katzenberger T, Hahn M, Rosenwald A, Ho AD, Müller-Hermelink HK, Lichter P, Krämer A.

Int J Cancer. 2007 Apr 15;120(8):1669-77.

20.

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.

Haralambieva E, Adam P, Ventura R, Katzenberger T, Kalla J, Höller S, Hartmann M, Rosenwald A, Greiner A, Muller-Hermelink HK, Banham AH, Ott G.

Leukemia. 2006 Jul;20(7):1300-3. Epub 2006 May 4. No abstract available.

PMID:
16673020
21.

The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma.

Katzenberger T, Petzoldt C, Höller S, Mäder U, Kalla J, Adam P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

Blood. 2006 Apr 15;107(8):3407. No abstract available.

22.

Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.

Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.

Genes Chromosomes Cancer. 2006 Feb;45(2):203-10.

PMID:
16258956
23.

Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Katzenberger T, Ott G, Klein T, Kalla J, Müller-Hermelink HK, Ott MM.

Am J Pathol. 2004 Aug;165(2):481-90.

24.

Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.

Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TF, Möller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Döhner H, Lichter P, Bentz M.

Blood. 2004 Aug 1;104(3):795-801. Epub 2004 Apr 13.

25.

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma.

Krämer A, Schweizer S, Neben K, Giesecke C, Kalla J, Katzenberger T, Benner A, Müller-Hermelink HK, Ho AD, Ott G.

Leukemia. 2003 Nov;17(11):2207-13.

PMID:
14523473
26.

Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.

Grønbaek K, Ralfkiaer E, Kalla J, Skovgaard GL, Guldberg P.

J Pathol. 2003 Sep;201(1):134-40.

PMID:
12950026
27.

Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas.

Zettl A, Meister S, Katzenberger T, Kalla J, Ott MM, Müller-Hermelink HK, Ott G.

Histopathology. 2003 Sep;43(3):209-19.

PMID:
12940773
28.

Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.

Katzenberger T, Lohr A, Schwarz S, Dreyling M, Schoof J, Nickenig C, Stilgenbauer S, Kalla J, Ott MM, Müller-Hermelink HK, Ott G.

Blood. 2003 Jan 15;101(2):699-702. Epub 2002 Aug 29.

29.

Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

Ott G, Katzenberger T, Lohr A, Kindelberger S, Rüdiger T, Wilhelm M, Kalla J, Rosenwald A, Müller JG, Ott MM, Müller-Hermelink HK.

Blood. 2002 May 15;99(10):3806-12.

30.

Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways.

Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, Müller-Hermelink HK.

Blood. 2002 Jan 1;99(1):3-9.

31.

A database system for comparative genomic hybridization analysis.

Berrar D, Dubitzky W, Solinas-Toldo S, Bulashevska S, Granzow M, Conrad C, Kalla J, Lichter P, Eils R.

IEEE Eng Med Biol Mag. 2001 Jul-Aug;20(4):75-83. No abstract available.

PMID:
11494773
32.

Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development.

Seeberger H, Starostik P, Schwarz S, Knörr C, Kalla J, Ott G, Müller-Hermelink HK, Greiner A.

Lab Invest. 2001 Jul;81(7):977-86.

PMID:
11454987
33.

[Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma].

Katzenberger T, Lohr A, Ott MM, Kalla J, Rosenwald A, Müller-Hermelink HK, Ott G.

Verh Dtsch Ges Pathol. 2000;84:153-61. German.

PMID:
11217435
34.

Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.

Kalla J, Stilgenbauer S, Schaffner C, Wolf S, Ott G, Greiner A, Rosenwald A, Döhner H, Müller-Hermelink HK, Lichter P.

Leukemia. 2000 Nov;14(11):1967-74.

PMID:
11069033
35.

Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities.

Ott MM, Rosenwald A, Katzenberger T, Dreyling M, Krumdiek AK, Kalla J, Greiner A, Ott G, Müller-Hermelink HK.

Genes Chromosomes Cancer. 2000 Aug;28(4):380-6.

PMID:
10862046
36.

Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.

Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, Greiner A, Ott MM, Gawin B, Döhner H, Müller-Hermelink HK.

Am J Pathol. 1999 Dec;155(6):1817-21.

37.

Report of the Sixth International Workshop on Human Chromosome 11 Mapping 1998. Nice, France, May 2-5, 1998.

Gaudray P, Carle GF, Gerhard DS, Gessler M, Mannens MM, Athanasiou M, Bliek J, Calender A, Debelenko LV, Devignes M, Evans GA, Favier R, Forbes S, Gaudray G, Gawin B, Gordon M, Grimmond S, Grossfeld P, Harris J, Hattori M, Hosoda F, Hummerich H, James M, Kalla J, Katsanis N, et al.

Cytogenet Cell Genet. 1999;86(3-4):167-86. No abstract available.

PMID:
10575203
38.

A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas?

Rosenwald A, Ott G, Krumdiek AK, Dreyling MH, Katzenberger T, Kalla J, Roth S, Ott MM, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1999 Nov;26(3):210-4.

PMID:
10502318
39.

t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma.

Rosenwald A, Ott G, Pulford K, Katzenberger T, Kühl J, Kalla J, Ott MM, Mason DY, Müller-Hermelink HK.

Blood. 1999 Jul 1;94(1):362-4.

40.

The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features.

Ott G, Kalla J, Hanke A, Müller JG, Rosenwald A, Katzenberger T, Kretschmar R, Kreipe H, Müller-Hermelink HK.

Leuk Lymphoma. 1998 Dec;32(1-2):55-63. Review.

PMID:
10037001
41.

Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma.

Rosenwald A, Ott G, Katzenberger T, Siebert R, Kalla J, Kuse R, Ott MM, Müller-Hermelink HK, Schlegelberger B.

Cancer Genet Cytogenet. 1999 Jan 1;108(1):53-6.

PMID:
9973925
42.

Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type.

Ott G, Kalla J, Steinhoff A, Rosenwald A, Katzenberger T, Roblick U, Ott MM, Müller-Hermelink HK.

Am J Pathol. 1998 Sep;153(3):689-94.

43.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798
44.

A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation.

Ott G, Bastian BC, Katzenberger T, Decoteau JF, Kalla J, Rosenwald A, Weissinger F, Ott MM, Kadin ME, Müller-Hermelink HK.

Br J Haematol. 1998 Jan;100(1):187-90.

PMID:
9450809
45.

Villous cytotrophoblast proliferating potential in complete and partial hydatidiform mole: diagnostic value of silver-stained nucleolar organizer region (AgNOR)-associated proteins.

Neudeck H, Unger M, Hufnagl P, Eiben B, Peters K, Kalla J, Graf R, Vogel M.

Gen Diagn Pathol. 1997 Nov;143(2-3):179-84.

PMID:
9443574
46.
47.

The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract.

Ott G, Kalla J, Ott MM, Müller-Hermelink HK.

Diagn Mol Pathol. 1997 Jun;6(3):134-9.

PMID:
9276184
48.

Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.

Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Müller JG, Müller-Hermelink HK.

Blood. 1997 Feb 15;89(4):1421-9.

49.

Genetic lesions in mantle cell lymphoma.

Ott G, Ott MM, Kalla J, Helbing A, Schryen B, Katzenberger T, Bartek J, Dürr A, Müller JG, Kreipe H, Müller-Hermelink HK.

Recent Results Cancer Res. 1997;143:307-19. Review. No abstract available.

PMID:
8912428
50.

[Detection of mixed lymphoid chimerism after allogeneic bone marrow transplantation: demonstration by interphase cytogenetics in paraffin-embedded tissue].

Friedrich T, Ott G, Kalla J, Helbig W, Schwenke H, Kubel M, Pönisch W, Feyer P, Friedrich A.

Verh Dtsch Ges Pathol. 1994;78:305-9. German.

PMID:
7534002

Supplemental Content

Support Center